SETD3 and breast carcinoma: Overall, these results demonstrate a role for SETD3 in cytoskeletal organization and function of aggressive breast cancer cells, which correlates with our observation that the expression of SETD3 in triple negative tumors was related to poor prognosis (Fig. 2D).